Nystatin Powder Quantity for Prescribing
For oral candidiasis, prescribe nystatin oral suspension (100,000 units/mL) in quantities of 60 mL to 480 mL depending on treatment duration, with typical dosing of 4–6 mL four times daily for 7–14 days, requiring approximately 112–336 mL total for a complete course.
Oral Candidiasis Dosing and Quantity Calculations
Standard Oral Suspension Regimen
- Nystatin oral suspension at 100,000 units/mL is dosed at 4–6 mL four times daily for 7–14 days 1
- For a 7-day course at 4 mL four times daily: 4 mL × 4 doses × 7 days = 112 mL total 1
- For a 14-day course at 6 mL four times daily: 6 mL × 4 doses × 14 days = 336 mL total 1
- Available bottle sizes are 60 mL and 480 mL, so prescribe accordingly based on treatment duration 2
Alternative Formulation: Pastilles
- Nystatin pastilles (200,000 units each) are dosed at 1–2 pastilles four times daily for 7–14 days as an alternative to suspension 1
- For a 14-day course: 2 pastilles × 4 doses × 14 days = 112 pastilles total 1
Strength of Recommendations
- These dosing regimens carry a strong recommendation with moderate-quality evidence from the Infectious Diseases Society of America 1
Vulvovaginal Candidiasis Considerations
Nystatin Intravaginal Suppositories
- For C. glabrata vulvovaginitis unresponsive to oral azoles, nystatin intravaginal suppositories at 100,000 units daily for 14 days are recommended 3
- This requires 14 suppositories total for a complete treatment course 3
- This is a strong recommendation with low-quality evidence 3
Important Caveat
- Topical azole agents or a single 150-mg dose of oral fluconazole are first-line for uncomplicated vulvovaginal candidiasis, not nystatin 3
- Nystatin suppositories are reserved for azole-refractory C. glabrata infections 3
Special Populations: Diabetes
No Dose Adjustment Required
- Nystatin exhibits negligible systemic absorption with no pharmacologic interactions with insulin or diabetes medications 1
- Do not withhold nystatin in diabetic patients due to diabetes concerns, as there is no pharmacologic basis for such withholding 1
- Standard dosing of 4–6 mL four times daily for 7–14 days remains appropriate in patients with diabetes 1
Monitoring Considerations
- Diabetic patients have heightened susceptibility to oral candidiasis due to immune dysfunction 1
- Monitor for treatment failure, as resistance (particularly C. glabrata) may require switching to fluconazole 100–200 mg daily for 7–14 days 1
Practical Prescribing Algorithm
For Oral Candidiasis (Most Common Indication)
- Mild-to-moderate disease: Prescribe one 60-mL bottle for a 7-day course at 4 mL four times daily 2
- Moderate-to-severe disease or longer duration: Prescribe one 480-mL bottle for a 14-day course at 6 mL four times daily 2
- Alternative: Prescribe 112 pastilles (200,000 units each) for a 14-day course at 2 pastilles four times daily 1
For Vulvovaginal Candidiasis (Azole-Refractory C. glabrata Only)
- Prescribe 14 intravaginal suppositories (100,000 units each) for daily use over 14 days 3
Common Pitfalls to Avoid
Underprescribing Volume
- Prescribing only 60 mL for a 14-day course at 6 mL four times daily will result in insufficient medication (need 336 mL total) 1, 2
- Always calculate total volume needed: mL per dose × 4 doses per day × number of days 1
Inappropriate First-Line Use for Vulvovaginal Candidiasis
- Nystatin is NOT first-line for uncomplicated vulvovaginal candidiasis—topical azoles or oral fluconazole are preferred 3
- Reserve nystatin suppositories specifically for azole-refractory C. glabrata infections 3